In a statement Novartis AG said, it has launched a new share buyback of up to $15 billion which will end by 2023. Confirming an expected sales growth by 4% through 2026, the Swiss pharma giant said its capital allocation strategy… Read More ›
Novartis AG
Gilead Science settles DoJ probe over U.S. kickbacks for Medicare patients with $97M
In a statement, the U.S. Department of Justice stated, Gilead Sciences Inc has agreed to settle allegations that it improperly used the Caring Voice Coalition as a conduit to cover thousands of patients’ co-payment obligations and has agreed to pay… Read More ›
Swiss drugmaker Novartis AG settles kickback charges for $729 Million: DoJ
In a statement, the U.S. Department of Justice said, Novartis AG has agreed to settle U.S. government charges that it had made illegal transfers, in the nature of kickbacks, to doctors and patients, in order to boost drug sales. Swiss… Read More ›
Swiss drugmaker Novartis AG close to acquiring U.S. biotechnology firm The Medicines Co for around $7 billion
According to a report from the Wall Street Journal, Swiss drugmaker Novartis AG is close to clinching an agreement to acquire U.S. biotechnology firm The Medicines Co for around $7 billion. In the potential deal, Novartis has agreed to pay… Read More ›
manageria.biz 